Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | Open Access Journal of Clinical Trials | journal | 0.192 Q3 | 15 | 8 | 19 | 278 | 14 | 19 | 0.83 | 34.75 | 53.85 |  |
| 12 | Fluoride - Quarterly Reports | journal | 0.429 Q3 | 51 | 44 | 130 | 1362 | 174 | 118 | 1.15 | 30.95 | 50.00 | |
| 11 | Drug, Healthcare and Patient Safety | journal | 0.481 Q3 | 30 | 11 | 54 | 470 | 102 | 54 | 1.07 | 42.73 | 26.00 | |
| 10 | Patient Preference and Adherence | journal | 0.727 Q1 | 67 | 209 | 612 | 7561 | 1308 | 598 | 1.89 | 36.18 | 52.11 | |
| 9 | Biomarker Insights | journal | 0.810 Q2 | 40 | 20 | 110 | 855 | 233 | 108 | 2.09 | 42.75 | 41.54 | |
| 8 | Core Evidence (discontinued) | journal | 0.813 Q2 | 29 | 2 | 26 | 110 | 83 | 25 | 2.62 | 55.00 | 20.00 | |
| 7 | Drug Design, Development and Therapy | journal | 0.974 Q1 | 94 | 323 | 1125 | 15037 | 3517 | 1099 | 3.05 | 46.55 | 40.37 | |
| 6 | International Journal of Nanomedicine | journal | 1.225 Q1 | 179 | 622 | 1565 | 31106 | 8024 | 1543 | 4.65 | 50.01 | 42.70 | |
| 5 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.342 Q1 | 64 | 52 | 162 | 2713 | 620 | 160 | 3.20 | 52.17 | 42.45 | |
| 4 | Pharmacogenomics and Personalized Medicine | journal | 1.353 Q1 | 37 | 31 | 66 | 1481 | 307 | 64 | 3.93 | 47.77 | 48.61 | |
| 3 | Infection and Drug Resistance | journal | 1.603 Q1 | 65 | 59 | 107 | 2241 | 527 | 105 | 4.13 | 37.98 | 41.43 | |
| 2 | Theranostics | journal | 2.515 Q1 | 158 | 358 | 394 | 20588 | 3701 | 388 | 8.90 | 57.51 | 39.04 |  |
| 1 | Nanotechnology, Science and Applications | journal | 2.723 Q1 | 35 | 15 | 16 | 689 | 249 | 16 | 13.90 | 45.93 | 39.71 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data